We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Minimising the risk of osteonecrosis of the jaw; monitoring for hypocalcaemia.
Patients should use the lowest effective dose, and the shortest duration of treatment necessary to control symptoms.
Employment Appeal Tribunal judgment of Mr Justice Langstaff on 25 March 2015.
Denosumab is associated with a risk of osteonecrosis of the jaw, osteonecrosis of the external auditory canal has also been reported with denosumab.
Maternity and neonatal services nationwide will be required to support and inform women who experience trauma during childbirth.
First published during the 2022 to 2024 Sunak Conservative government
Updated advice on use of nicorandil as second-line treatment for stable angina - some ulcers may progress to complications unless treatment is stopped.
Upper Tribunal Administrative Appeals Chamber decision by Judge Lane on 31 October 2017.
Employment Appeal Tribunal judgment of Mrs Justice Eady on 17 October 2019.
Public Health England (PHE) publishes first data briefing on neurology outpatient services in England.
Upper Tribunal Administrative Appeals Chamber decision by Judge Wright on 15 September 2016.
Employment Tribunal decision.
Nicorandil is associated with a risk of gastrointestinal ulceration including perianal ulceration.
Upper Tribunal Administrative Appeals Chamber decision by Judge Perez on 18 April 2018.
Upper Tribunal Administrative Appeals Chamber decision by Judge Rowley on 16 March 2016.
Prescribing advice should be followed carefully, particularly recommended upper dose limits due to associated higher gastrointestinal risk than most other NSAIDs in the class.
Upper Tribunal Administrative Appeals Chamber decision by Judge Rowland on 18 May 2016.
Employment Appeal Tribunal judgment of Naomi Ellenbogen (Deputy Judge of the High Court) on 21 February 2020.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).